China IP Forum

left Nav

Forum Program

Thursday, May 24, 2012
Registration and Welcome Reception
10:00-17:30 Registration
15:30-16:30 CMC Tour
17:00-17:45 Introduction to CMC (VIP Conference Room, Traders Oriental Hotel, TaiZhou)
18:00 -21:00Welcome Reception /Banquet (Traders Oriental Hotel, TaiZhou)

Friday, May 25, 2012
Morning Plenary Session: Keynote Speeches
8:30 - 10:15Opening Remarks

Chaired by Shaoning Gan, Deputy Commissioner, SIPO

  • Lei Zhang, General Secretary of CPC, Taizhou, China
  • Marinda Wu, President-Elect, American Chemical Society (ACS)
  • Maicun Deng, Secretary-General of Chinese Academy of Sciences
  • Weixing Cao, Deputy Governor of Jiangsu Province, China
  • Lipu Tian, Commissioner of SIPO, China
Keynote Presentation: Servicing Innovation and Promoting Development – Overview of China Patent System Operating
  • David Kappos, Under Secretary for Commerce and Director of the USPTO, USA
Keynote Presentation: How Does the America Invents Act Enhance Global Commerce
10:15 - 10:20Tea Break
10:20 - 11:30

Chaired by Hao Ma, President of China Council for the Promotion of International Trade Patent and Trademark Law Office (CCPIT)

  • Sharon Prost , Circuit Judge, The United States Court of Appeals for the Federal Circuit, USA
  • Keynote Presentation: Patent Law: Taking Center Stage in the 21st Century, A View from the Bench
  • XiangJun Kong, Chief Justice,Intellectual Property Tribunal, the Supreme People's Court, China
  • Robert DeBerardine, Vice President and Global Head of Patent, Sanofi
  • Keynote Presentation: Legal Certainty and Business Investment
11:30 - 12:30Press Conference for Patented Innovation

Chaired by Marinda Wu, President-elect ACS & Sunny Wang, Secretary General of Tri-State CACS

Presentation (10 min for each presenter)
12:30 - 14:00Lunch Break & Social Networking
Afternoon Plenary Session: Inventions and Patent Strategies
14:00 –15:45 Session I

Panel Presentation on Comparisons in Patent Examination among EU, US, JP and CN: Patent examination officials will present and discuss their respective country's standards for patentability, with a focus on inventive step (non-obviousness) and enablement, including data disclosure in regards to the breadth of claims that may be granted. The session will conclude with comparison of the similarities and differences in patentability standards among the countries.

Chaired by Xiangling Zeng, President of China Patent Agent (H.K.) Ltd.

15:45 - 16:00Tea Break
16:00 - 18:00 Session II

Panel Presentation of Patent Prosecution and IP Protection: Senior patent attorneys from the US, Europe, Korea,and other Asian countries will present and discuss their patent application preparation and prosecution strategies to address the patentability standards of USPTO, EPO, KIPO, JPO, and SIPO with an emphasis on addressing the patentability standards in their home country/region.

Chaired by Dominique Kugel, Global Head of TSU Patent Support, Sanofi

  • Introduction

  • Topic: Life Science and Pharma Patents – Pitfalls and Tips
  • Speaker: MaryAnne Armstrong, Partner, BSKB, USA

  • Topic: EPO Patent Prosecution and IP Protection
  • Speaker: Leo Polz , Partner, Hoffmann Eitle, Germany

  • Topic: The Latest IP Legal Developments Affecting the Korean Pharmaceutical Field
  • Speaker: Jay Kim, Partner; Kim & Chang, Korea

  • Topic: Recent Amendments of Patents Regimes in South East Asia and Australia
  • Speaker: Kristian Robinson & Andrew Blattman, Partner, Ella Cheong Spruson & Ferguson, Singapore

  • Topic:New Trends/Implications of Patent Examination in Pharmaceutical Field from the Perspective of Recent Decisions by China Supreme People’s Court on Two Pharmaceutical Inventions
  • Speaker: Tina Hong Tai, Partner and VP, China Patent Agent (H.K.) Ltd., China

  • Q&A
Evening Program
18:30-21:30Dinner (Invited Guests Only)

Saturday, May 26, 2012
Morning Plenary Session: Invention, Externalization and IP Transfer
8:30 – 10:15 Session III

Panel Presentation on Invention, IP Transfer and Commercialization: Universities and academic research institutions are the primary centers of innovation in China. How to turn innovative ideas from these academic institutions into economic activities that create jobs and financial returns remains a challenge for China’s leaders in academia, government and industry. We have assembled an excellent panel from some of the world’s most prominent and successful organizations in technology transfer, who will share their valuable experience.

Chaired by Kening Li, General Counsel, Chinese Biopharmaceutical Association (CBA) China

  • Introduction

  • Topic: Pioneer Drug Discovery in China
  • Speaker: Hualiang Jiang , Vice-Director of the Shanghai Institute of Materia Medica, CAS, PRC

  • Topic: From Labs to Market: University Technology Transfer in the U.S
  • Speaker: Beth Werner, Senior IP Manager, Wisconsin Alumni Research Foundation (WARF), USA

  • Topic: Winning Strategy for Technology Transfer and Alliances with Business Partners
  • Speaker: Gil Granot-Mayer, Adv. General Counsel, Yeda Research & Development Co. Ltd. Israel;

  • Topic: China Medical City: An Incubator for Research-Based Companies
  • Speaker: David Yinghao Sun, Deputy Director and Chief Technology Officer at China Medical City, PRC;

  • Topic:Creation and Management of Biotech and High-tech Ventures
  • Speaker: Mark Chilung Tang, Chairman of WT Global Capital Inc.,USA

  • Q&A
10:15 - 10:30Tea Break
10:30 - 12:15 Session IV

Panel Presentation on IP Protection In Externalization & CRO Outsourcing: This panel will focus on protecting intellectual property rights in external collaborations.

Chaired by Mingqiang Zhang, General Manager & VP & Head of Asia Pacific R&D, Merck Sharp & Dohme

12:15 - 14:00Lunch Break & Social Networking
Afternoon Plenary Session: Biological Development & Invention Enforcement
14:00 – 15:50 Session V

Panel Presentations on Biological Drug Development: This panel will discuss new challenges to obtaining and enforcing patents on biotech inventions. The panel will touch on patentable subject matter; what biotech inventions should be patented; the obviousness standard as applied to biotech inventions; the need for sufficient patent term given long product development timelines; and the need for effective relief following successful patent enforcement.

Chaired by Stuart Watt , SVP & Chief IP Counsel, Amgen, USA

15:50- 16:00Tea Break
16:00- 18:00 Session VI

Panel Presentations & Discussion on Patent Enforcement: This panel will discuss recent developments in patent litigation in Europe and the US, including Hatch-Waxman litigation. The presentations will also cover patent enforcement and defensive strategies.

Chaired by Peter Dolan, Head of Asia Pacific Patent Support, Sanofi

Evening Program
18:00-21:00Dinner (Invited Guests Only)

Sunday, May 27, 2012
Morning Plenary Session: China Hot Topics
8:30-10:30 Session VII

China Pharmaceutical Hot Topics: From drug pricing policies to practices, from pharmaceutical data protection to trademark issues, the leaders in these fields will give insightful presentations and reviews.

Chaired by Deshan Li , Vice-President of Unitalen Attorneys, China

  • Topic: China Drug Pricing Policies and Practices
  • Speaker: Linjia Weng , Director of National Development and Reform Commission, China

  • Topic: Pharmaceutical Data Protection
  • Speaker: Bing Chen, VP of Chinese Pharmaceutical Association, China

  • Topic: Drug’s Trademark Protection
  • Speaker: XinHua Wu, The State Administration for Industry & Commerce of China
10:30 – 10:45Tea Break
10:45 – 11:45 Session VIII

Roundtable Discussion on Patent Procurement and Enforcement in China:
Panelists in this roundtable discussion are from the judiciary, SIPO, multinational pharma, domestic Chinese pharma, and private practice. The panel will have an interactive dialogue on hot issues in patent protection and enforcement in pharmaceutical and life sciences in China. The topics will include how to protect innovations via strong patents, how to effectively enforce patents, and what should be taken into consideration when making deals. Panel members will also provide suggestions and tips on pre-litigation preparation and litigation.

Chaired by Ningling Wang, Partner, Finnegan Henderson

  • Xia Lou, Judge, Supreme Court, China
  • Guiming Liu, Deputy Director of Chemical Group, SIPO, China
  • Amy Feng, Partner, Liu-Shen Associates, China
  • David Shen, IP Counsel, AstraZeneca, China
  • Yang Xu, IP Director, Simcere, China
11:45 – 12:15Closing Remarks

Chaired by Yue Wu, Director General of CMC

  • Yuncai Zhang, Secretary General of CNIPS, China
  • Fanwen Zeng, President, Tri-State CACS, USA
12:15 – 13:30Lunch
Afternoon: Special Program
Round Table Discussion With CMC Research Companies & Decision Makers (invited guests only)
City Tour of TaiZhou

Back to Top


China International Intellectual Property Forum Committee Copyright © 2006-2019
All rights reserved.

Web designing by